Retraction Note: Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial

Retraction Note: Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial

Guardado en:
Detalles Bibliográficos
Autores principales: Hany M. Dabbous, Manal H. El‑Sayed, Gihan El Assal, Hesham Elghazaly, Fatma F. S. Ebeid, Ahmed F. Sherief, Maha Elgaafary, Ehab Fawzy, Sahar M. Hassany, Ahmed R. Riad, Mohamed A. TagelDin
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/4b565f65ac4a46f0bd15948e52f78885
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4b565f65ac4a46f0bd15948e52f78885
record_format dspace
spelling oai:doaj.org-article:4b565f65ac4a46f0bd15948e52f788852021-12-02T18:34:01ZRetraction Note: Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial10.1038/s41598-021-98683-52045-2322https://doaj.org/article/4b565f65ac4a46f0bd15948e52f788852021-09-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-98683-5https://doaj.org/toc/2045-2322Hany M. DabbousManal H. El‑SayedGihan El AssalHesham ElghazalyFatma F. S. EbeidAhmed F. SheriefMaha ElgaafaryEhab FawzySahar M. HassanyAhmed R. RiadMohamed A. TagelDinNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-1 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Hany M. Dabbous
Manal H. El‑Sayed
Gihan El Assal
Hesham Elghazaly
Fatma F. S. Ebeid
Ahmed F. Sherief
Maha Elgaafary
Ehab Fawzy
Sahar M. Hassany
Ahmed R. Riad
Mohamed A. TagelDin
Retraction Note: Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial
format article
author Hany M. Dabbous
Manal H. El‑Sayed
Gihan El Assal
Hesham Elghazaly
Fatma F. S. Ebeid
Ahmed F. Sherief
Maha Elgaafary
Ehab Fawzy
Sahar M. Hassany
Ahmed R. Riad
Mohamed A. TagelDin
author_facet Hany M. Dabbous
Manal H. El‑Sayed
Gihan El Assal
Hesham Elghazaly
Fatma F. S. Ebeid
Ahmed F. Sherief
Maha Elgaafary
Ehab Fawzy
Sahar M. Hassany
Ahmed R. Riad
Mohamed A. TagelDin
author_sort Hany M. Dabbous
title Retraction Note: Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial
title_short Retraction Note: Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial
title_full Retraction Note: Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial
title_fullStr Retraction Note: Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial
title_full_unstemmed Retraction Note: Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial
title_sort retraction note: safety and efficacy of favipiravir versus hydroxychloroquine in management of covid-19: a randomised controlled trial
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/4b565f65ac4a46f0bd15948e52f78885
work_keys_str_mv AT hanymdabbous retractionnotesafetyandefficacyoffavipiravirversushydroxychloroquineinmanagementofcovid19arandomisedcontrolledtrial
AT manalhelsayed retractionnotesafetyandefficacyoffavipiravirversushydroxychloroquineinmanagementofcovid19arandomisedcontrolledtrial
AT gihanelassal retractionnotesafetyandefficacyoffavipiravirversushydroxychloroquineinmanagementofcovid19arandomisedcontrolledtrial
AT heshamelghazaly retractionnotesafetyandefficacyoffavipiravirversushydroxychloroquineinmanagementofcovid19arandomisedcontrolledtrial
AT fatmafsebeid retractionnotesafetyandefficacyoffavipiravirversushydroxychloroquineinmanagementofcovid19arandomisedcontrolledtrial
AT ahmedfsherief retractionnotesafetyandefficacyoffavipiravirversushydroxychloroquineinmanagementofcovid19arandomisedcontrolledtrial
AT mahaelgaafary retractionnotesafetyandefficacyoffavipiravirversushydroxychloroquineinmanagementofcovid19arandomisedcontrolledtrial
AT ehabfawzy retractionnotesafetyandefficacyoffavipiravirversushydroxychloroquineinmanagementofcovid19arandomisedcontrolledtrial
AT saharmhassany retractionnotesafetyandefficacyoffavipiravirversushydroxychloroquineinmanagementofcovid19arandomisedcontrolledtrial
AT ahmedrriad retractionnotesafetyandefficacyoffavipiravirversushydroxychloroquineinmanagementofcovid19arandomisedcontrolledtrial
AT mohamedatageldin retractionnotesafetyandefficacyoffavipiravirversushydroxychloroquineinmanagementofcovid19arandomisedcontrolledtrial
_version_ 1718377917327605760

Ejemplares similares